(Q37810900)

23 August 2017

title

Pharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorder (English)

1 reference

attention deficit hyperactivity disorder

23 August 2017

main subject

0 references

1 reference

1 reference

1

James C Ermer

1 reference

23 August 2017

Ben A Adeyi

2

1 reference

23 August 2017

Michael L Pucci

series ordinal

3

1 reference

23 August 2017

publication date

1 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

24

1 reference

23 August 2017

issue

12

1 reference

23 August 2017

page(s)

1009-1025

1 reference

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11539410-000000000-00000

Levoamphetamine vs dextroamphetamine in minimal brain dysfunction. Replication, time response, and differential effect by diagnostic group and family rating

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539410-000000000-00000

Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539410-000000000-00000

Gastrointestinal transit of Oros drug delivery systems in healthy volunteers: a short report

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539410-000000000-00000

Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539410-000000000-00000

Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N-labelled drug to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539410-000000000-00000

21 January 2018

1 reference

12 December 2020

Effect of dosing time on the total intestinal transit time of non-disintegrating systems

1 reference

12 December 2020

Contribution to variability in response to opioids

1 reference

12 December 2020

Bioequivalence approaches for highly variable drugs and drug products

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of an oral mixed amphetamine salts extended-release formulation in adults.

1 reference

12 December 2020

Clinical correlates of methylphenidate blood levels.

1 reference

12 December 2020

A guide to the treatment of adults with ADHD.

1 reference

12 December 2020

Association of norepinephrine transporter gene with methylphenidate response

1 reference

12 December 2020

Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults

1 reference

12 December 2020

Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder

1 reference

12 December 2020

Plasma levels of d-amphetamine in hyperactive children. Serial behavior and motor responses

1 reference

12 December 2020

Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial

1 reference

12 December 2020

Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects

1 reference

12 December 2020

Relative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: a single-dose, crossover pharmacokinetic study

1 reference

12 December 2020

Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study

1 reference

12 December 2020

Managing attention deficit/hyperactivity disorder: unmet needs and future directions

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Population pharmacokinetics I: background, concepts, and models

1 reference

12 December 2020

A clinically relevant review of tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and effectiveness in healthy subjects and patients

1 reference

12 December 2020

Adderall XR: long acting stimulant for single daily dosing

1 reference

12 December 2020

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall

1 reference

12 December 2020

Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation

1 reference

12 December 2020

Sustained release methylphenidate: pharmacokinetic studies in ADDH males

1 reference

12 December 2020

Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement

1 reference

12 December 2020

Dose-proportional and stereospecific pharmacokinetics of methylphenidate delivered using an osmotic, controlled-release oral delivery system

1 reference

12 December 2020

Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Pharmacokinetic modeling and simulation of gastrointestinal transit effects on plasma concentrations of drugs from mixed immediate-release and enteric-coated pellet formulations

1 reference

12 December 2020

Nonspecific medication side effects and the nocebo phenomenon

1 reference

12 December 2020

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine

1 reference

12 December 2020

New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential

1 reference

12 December 2020

Pharmacokinetics and Clinical Effectiveness of Methylphenidate

1 reference

12 December 2020

Sex differences in the response of children with ADHD to once-daily formulations of methylphenidate

1 reference

12 December 2020

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic variability: a daunting challenge in drug therapy

1 reference

12 December 2020

Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults

1 reference

12 December 2020

Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial.

1 reference

12 December 2020

The stimulants revisited.

1 reference

12 December 2020

The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?

1 reference

12 December 2020

Effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR Food Evaluation (CAFE) Study

1 reference

12 December 2020

Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder

1 reference

12 December 2020

Safety and tolerability of methylphenidate in preschool children with ADHD.

1 reference

12 December 2020

Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey.

1 reference

12 December 2020

Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD

1 reference

12 December 2020

Application of population pharmacokinetics to the optimization of theophylline therapy.

1 reference

12 December 2020

Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin

1 reference

12 December 2020

Attention-deficit/hyperactivity disorder: medication treatment-dosing and duration of action.

1 reference

12 December 2020

Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments

1 reference

12 December 2020

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

12 December 2020

New insights into the placebo and nocebo responses

1 reference

12 December 2020

Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

1 reference

12 December 2020

Dose-proportional pharmacokinetics of d-threo-methylphenidate after a repeated-action release dosage form

1 reference

12 December 2020

Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover

1 reference

12 December 2020

Dose-proportional pharmacokinetics of a methylphenidate extended-release capsule.

1 reference

12 December 2020

Advances in the Pharmacotherapy of Attention‐Deficit‐Hyperactivity Disorder: Focus on Methylphenidate Formulations

1 reference

12 December 2020

Effects of food on the pharmacokinetics of methylphenidate

1 reference

12 December 2020

Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications

1 reference

12 December 2020

Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy

1 reference

12 December 2020

Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate

1 reference

12 December 2020

Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study

1 reference

12 December 2020

Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, cro

1 reference

12 December 2020

Metabolism, distribution and elimination of lisdexamfetamine dimesylate: open-label, single-centre, phase I study in healthy adult volunteers

1 reference

12 December 2020

ADHD: new pharmacological treatments on the horizon

1 reference

12 December 2020

Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Lisdexamfetamine dimesylate: linear dose-proportionality, low intersubject and intrasubject variability, and safety in an open-label single-dose pharmacokinetic study in healthy adult volunteers

1 reference

12 December 2020

Population pharmacokinetics of methylphenidate in children with attention-deficit hyperactivity disorder

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation

1 reference

12 December 2020

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

1 reference

12 December 2020

10.2165/11539410-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

1000799752

0 references

Fatcat ID

release_bzo2bno73bgxnc47owrjhhpelm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bzo2bno73bgxnc47owrjhhpelm

24 November 2022

mapped directly with Wikidata item

1 reference